This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murray, H. W.
Right arrow Articles by Coffman, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murray, H. W.
Right arrow Articles by Coffman, R. L.

 Previous Article  |  Next Article 

Infection and Immunity, November 2002, p. 6284-6293, Vol. 70, No. 11
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.11.6284-6293.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy

Henry W. Murray,1* Christina M. Lu,1 Smita Mauze,2 Sherry Freeman,3 Andre L. Moreira,4 Gilla Kaplan,3 and Robert L. Coffman2,{dagger}

Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021,1 Department of Immunology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, California 94304,2 Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021,3 Department of Pathology, New York University School of Medicine, New York, New York 100164

Received 11 March 2002/ Returned for modification 22 May 2002/ Accepted 11 June 2002

Interleukin-10 (IL-10) is thought to promote intracellular infection, including human visceral leishmaniasis, by disabling Th1 cell-type responses and/or deactivating parasitized tissue macrophages. To develop a rationale for IL-10 inhibition as treatment in visceral infection, Th1 cytokine-driven responses were characterized in Leishmania donovani-infected BALB/c mice in which IL-10 was absent or overexpressed or its receptor (IL-10R) was blockaded. IL-10 knockout and normal mice treated prophylactically with anti-IL-10R demonstrated accelerated granuloma assembly and rapid parasite killing without untoward tissue inflammation; IL-12 and gamma interferon mRNA expression, inducible nitric oxide synthase reactivity, and responsiveness to antimony chemotherapy were also enhanced in knockout mice. In IL-10 transgenic mice, parasite replication was unrestrained, and except for antimony responsiveness, measured Th1 cell-dependent events were all initially impaired. Despite subsequent granuloma assembly, high-level infection persisted, and antimony-treated transgenic mice also relapsed. In normal mice with established infection, anti-IL-10R treatment was remarkably active, inducing near-cure by itself and synergism with antimony. IL-10's deactivating effects regulate outcome in experimental visceral leishmaniasis, and IL-10R blockade represents a potential immuno- and/or immunochemotherapeutic approach in this infection.

* Corresponding author. Mailing address: Box 136, 1300 York Avenue, New York, NY 10021. Phone: (212) 746-6330. Fax: (212) 746-6332. E-mail: hwmurray{at}med.cornell.edu.

Editor: J. M. Mansfield

{dagger} Present address: Dynavax Technologies, Berkeley, CA 94710.

Infection and Immunity, November 2002, p. 6284-6293, Vol. 70, No. 11
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.11.6284-6293.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Bhowmick, S., Mazumdar, T., Ali, N. (2009). Vaccination Route That Induces Transforming Growth Factor {beta} Production Fails To Elicit Protective Immunity against Leishmania donovani Infection. Infect. Immun. 77: 1514-1523 [Abstract] [Full Text]  
  • Murray, H. W. (2008). Accelerated Control of Visceral Leishmania donovani Infection in Interleukin-6-Deficient Mice. Infect. Immun. 76: 4088-4091 [Abstract] [Full Text]  
  • Manandhar, K. D., Yadav, T. P., Prajapati, V. K., Kumar, S., Rai, M., Dube, A., Srivastava, O. N., Sundar, S. (2008). Antileishmanial activity of nano-amphotericin B deoxycholate. J Antimicrob Chemother 62: 376-380 [Abstract] [Full Text]  
  • Banerjee, A., De, M., Ali, N. (2008). Complete Cure of Experimental Visceral Leishmaniasis with Amphotericin B in Stearylamine-Bearing Cationic Liposomes Involves Down-Regulation of IL-10 and Favorable T Cell Responses. J. Immunol. 181: 1386-1398 [Abstract] [Full Text]  
  • Salhi, A., Rodrigues, V. Jr., Santoro, F., Dessein, H., Romano, A., Castellano, L. R., Sertorio, M., Rafati, S., Chevillard, C., Prata, A., Alcais, A., Argiro, L., Dessein, A. (2008). Immunological and Genetic Evidence for a Crucial Role of IL-10 in Cutaneous Lesions in Humans Infected with Leishmania braziliensis. J. Immunol. 180: 6139-6148 [Abstract] [Full Text]  
  • Anderson, C. F., Lira, R., Kamhawi, S., Belkaid, Y., Wynn, T. A., Sacks, D. (2008). IL-10 and TGF-{beta} Control the Establishment of Persistent and Transmissible Infections Produced by Leishmania tropica in C57BL/6 Mice. J. Immunol. 180: 4090-4097 [Abstract] [Full Text]  
  • McFarlane, E., Perez, C., Charmoy, M., Allenbach, C., Carter, K. C., Alexander, J., Tacchini-Cottier, F. (2008). Neutrophils Contribute to Development of a Protective Immune Response during Onset of Infection with Leishmania donovani. Infect. Immun. 76: 532-541 [Abstract] [Full Text]  
  • Maroof, A., Kaye, P. M. (2008). Temporal Regulation of Interleukin-12p70 (IL-12p70) and IL-12-Related Cytokines in Splenic Dendritic Cell Subsets during Leishmania donovani Infection. Infect. Immun. 76: 239-249 [Abstract] [Full Text]  
  • Saha, S., Mondal, S., Ravindran, R., Bhowmick, S., Modak, D., Mallick, S., Rahman, M., Kar, S., Goswami, R., Guha, S. K., Pramanik, N., Saha, B., Ali, N. (2007). IL-10- and TGF-beta-Mediated Susceptibility in Kala-azar and Post-kala-azar Dermal Leishmaniasis: The Significance of Amphotericin B in the Control of Leishmania donovani Infection in India. J. Immunol. 179: 5592-5603 [Abstract] [Full Text]  
  • Silvestre, R., Cordeiro-Da-Silva, A., Santarem, N., Vergnes, B., Sereno, D., Ouaissi, A. (2007). SIR2-Deficient Leishmania infantum Induces a Defined IFN-{gamma}/IL-10 Pattern That Correlates with Protection. J. Immunol. 179: 3161-3170 [Abstract] [Full Text]  
  • Nagase, H., Jones, K. M., Anderson, C. F., Noben-Trauth, N. (2007). Despite Increased CD4+Foxp3+ Cells within the Infection Site, BALB/c IL-4 Receptor-Deficient Mice Reveal CD4+Foxp3-Negative T Cells as a Source of IL-10 in Leishmania major Susceptibility. J. Immunol. 179: 2435-2444 [Abstract] [Full Text]  
  • Roque, S., Nobrega, C., Appelberg, R., Correia-Neves, M. (2007). IL-10 Underlies Distinct Susceptibility of BALB/c and C57BL/6 Mice to Mycobacterium avium Infection and Influences Efficacy of Antibiotic Therapy. J. Immunol. 178: 8028-8035 [Abstract] [Full Text]  
  • Anderson, C. F., Oukka, M., Kuchroo, V. J., Sacks, D. (2007). CD4+CD25-Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. JEM 204: 285-297 [Abstract] [Full Text]  
  • Yang, Z., Mosser, D. M., Zhang, X. (2007). Activation of the MAPK, ERK, following Leishmania amazonensis Infection of Macrophages. J. Immunol. 178: 1077-1085 [Abstract] [Full Text]  
  • Sun, X., Jones, H. P., Hodge, L. M., Simecka, J. W. (2006). Cytokine and Chemokine Transcription Profile during Mycoplasma pulmonis Infection in Susceptible and Resistant Strains of Mice: Macrophage Inflammatory Protein 1{beta} (CCL4) and Monocyte Chemoattractant Protein 2 (CCL8) and Accumulation of CCR5+ Th Cells.. Infect. Immun. 74: 5943-5954 [Abstract] [Full Text]  
  • Bodas, M., Jain, N., Awasthi, A., Martin, S., Penke Loka, R. K., Dandekar, D., Mitra, D., Saha, B. (2006). Inhibition of IL-2 Induced IL-10 Production as a Principle of Phase-Specific Immunotherapy. J. Immunol. 177: 4636-4643 [Abstract] [Full Text]  
  • Hassan, M. F., Zhang, Y., Engwerda, C. R., Kaye, P. M., Sharp, H., Bickle, Q. D. (2006). The Schistosoma mansoni Hepatic Egg Granuloma Provides a Favorable Microenvironment for Sustained Growth of Leishmania donovani. Am. J. Pathol. 169: 943-953 [Abstract] [Full Text]  
  • Murray, H. W., Tsai, C. W., Liu, J., Ma, X. (2006). Responses to Leishmania donovani in Mice Deficient in Interleukin-12 (IL-12), IL-12/IL-23, or IL-18. Infect. Immun. 74: 4370-4374 [Abstract] [Full Text]  
  • Murray, H. W., Tsai, C. W., Liu, J., Ma, X. (2006). Visceral Leishmania donovani Infection in Interleukin-13-/- Mice. Infect. Immun. 74: 2487-2490 [Abstract] [Full Text]  
  • Wanderley, J. L. M., Moreira, M. E. C., Benjamin, A., Bonomo, A. C., Barcinski, M. A. (2006). Mimicry of Apoptotic Cells by Exposing Phosphatidylserine Participates in the Establishment of Amastigotes of Leishmania (L) amazonensis in Mammalian Hosts. J. Immunol. 176: 1834-1839 [Abstract] [Full Text]  
  • Woolard, M. D., Hudig, D., Tabor, L., Ivey, J. A., Simecka, J. W. (2005). NK Cells in Gamma-Interferon-Deficient Mice Suppress Lung Innate Immunity against Mycoplasma spp.. Infect. Immun. 73: 6742-6751 [Abstract] [Full Text]  
  • Murray, H. W., Flanders, K. C., Donaldson, D. D., Sypek, J. P., Gotwals, P. J., Liu, J., Ma, X. (2005). Antagonizing Deactivating Cytokines To Enhance Host Defense and Chemotherapy in Experimental Visceral Leishmaniasis. Infect. Immun. 73: 3903-3911 [Abstract] [Full Text]  
  • Basu, R., Bhaumik, S., Basu, J. M., Naskar, K., De, T., Roy, S. (2005). Kinetoplastid Membrane Protein-11 DNA Vaccination Induces Complete Protection against Both Pentavalent Antimonial-Sensitive and -Resistant Strains of Leishmania donovani That Correlates with Inducible Nitric Oxide Synthase Activity and IL-4 Generation: Evidence for Mixed Th1- and Th2-Like Responses in Visceral Leishmaniasis. J. Immunol. 174: 7160-7171 [Abstract] [Full Text]  
  • Murray, H. W. (2005). Prevention of Relapse after Chemotherapy in a Chronic Intracellular Infection: Mechanisms in Experimental Visceral Leishmaniasis. J. Immunol. 174: 4916-4923 [Abstract] [Full Text]  
  • Miles, S. A., Conrad, S. M., Alves, R. G., Jeronimo, S. M.B., Mosser, D. M. (2005). A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. JEM 201: 747-754 [Abstract] [Full Text]  
  • Mendez, S., Reckling, S. K., Piccirillo, C. A., Sacks, D., Belkaid, Y. (2004). Role for CD4+ CD25+ Regulatory T Cells in Reactivation of Persistent Leishmaniasis and Control of Concomitant Immunity. JEM 200: 201-210 [Abstract] [Full Text]  
  • Norsworthy, N. B., Sun, J., Elnaiem, D., Lanzaro, G., Soong, L. (2004). Sand Fly Saliva Enhances Leishmania amazonensis Infection by Modulating Interleukin-10 Production. Infect. Immun. 72: 1240-1247 [Abstract] [Full Text]  
  • Murray, H. W., Lu, C. M., Brooks, E. B., Fichtl, R. E., DeVecchio, J. L., Heinzel, F. P. (2003). Modulation of T-Cell Costimulation as Immunotherapy or Immunochemotherapy in Experimental Visceral Leishmaniasis. Infect. Immun. 71: 6453-6462 [Abstract] [Full Text]  
  • Padigel, U. M., Alexander, J., Farrell, J. P. (2003). The Role of Interleukin-10 in Susceptibility of BALB/c Mice to Infection with Leishmania mexicana and Leishmania amazonensis. J. Immunol. 171: 3705-3710 [Abstract] [Full Text]  
  • Murray, H. W., Brooks, E. B., DeVecchio, J. L., Heinzel, F. P. (2003). Immunoenhancement Combined with Amphotericin B as Treatment for Experimental Visceral Leishmaniasis. Antimicrob. Agents Chemother. 47: 2513-2517 [Abstract] [Full Text]  
  • Noben-Trauth, N., Lira, R., Nagase, H., Paul, W. E., Sacks, D. L. (2003). The Relative Contribution of IL-4 Receptor Signaling and IL-10 to Susceptibility to Leishmania major. J. Immunol. 170: 5152-5158 [Abstract] [Full Text]  
  • Murray, H. W. (2002). Kala-Azar -- Progress against a Neglected Disease. NEJM 347: 1793-1794 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»